Oncotelic Therapeutics Inc (OTLC) Stock: What Does the Chart Say Tuesday?

Tuesday, June 28, 2022 11:53 AM | InvestorsObserver Analysts

Mentioned in this article

Oncotelic Therapeutics Inc (OTLC) Stock: What Does the Chart Say Tuesday?

Overall market sentiment has been high on Oncotelic Therapeutics Inc (OTLC) stock lately. OTLC receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Oncotelic Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on OTLC!

See Full OTLC Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With OTLC Stock Today?

Oncotelic Therapeutics Inc (OTLC) stock is unchanged -0.06% while the S&P 500 is lower by -1% as of 11:29 AM on Tuesday, Jun 28. OTLC is flat $0.00 from the previous closing price of $0.16 on volume of 135,916 shares. Over the past year the S&P 500 is down -10.01% while OTLC is lower by -27.27%. OTLC lost -$0.03 per share in the over the last 12 months. To screen for more stocks like Oncotelic Therapeutics Inc click here.

More About Oncotelic Therapeutics Inc

Oncotelic Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing drugs for the treatment of orphan oncology indications, developing antisense and small molecule injectable drugs for the treatment of cancer with a focus on rare pediatric cancers, and addressing the current global pandemic. OT-101 is its lead immuno-oncology drug candidate. OT-101 also has activity against SARS-CoV-2. Its other products under pipeline are Artemisinin, CA4P, and Oxi4503. Currently, the company generates revenues from rendering services to other third-party customers for the development of certain drug products or in connection with certain out-licensing agreements. Click Here to get the full Stock Report for Oncotelic Therapeutics Inc stock.